Researchers Warn Trans Cardiovascular Risks Are Dangerously Understudied
The story so far
Researchers from Boston University, the University of Toronto and Yale University concluded in a perspective piece in the Journal of General Internal Medicine that cardiovascular health risks for trans people, especially possible interactions with hormone replacement therapy, are dangerously understudied. They called for research beyond gender-affirming hormone therapy. The authors noted that trans, gender-nonconforming and nonbinary people make up 1.1% of U.S. adults yet appear to face disproportionate cardiovascular disease rates, regardless of whether they take hormones, according to them. They also cited minority stress from stigma and discriminatory policies as an area for further study, and noted that cardiovascular disease accounts for 26.4% of all U.S. deaths.
Written by AI from the reports · updated 2 hrs ago
Timeline
Follow the coverage to see every side of the story.
- The AdvocateTrans People's Cardiovascular Risk Is Dangerously Understudied, Researchers Warn
Researchers from Boston University, University of Toronto and Yale University concluded in a Journal of General Internal Medicine perspective piece that cardiovascular risks for trans people, especially involving hormone replacement therapy, are dangerously understudied.
- OutAre Trans People More Susceptible to Cardiovascular Disease? Researchers Still Have Questions
A new perspective piece in the Journal of General Internal Medicine concludes that cardiovascular risks for trans people, especially around hormone replacement therapy, are dangerously understudied. Researchers from Boston University, University of Toronto and Yale University note that trans, gender-nonconforming and nonbinary people make up 1.1% of the U.S. adult population yet show disproportionate CVD rates, and call for research beyond gender-affirming hormone therapy.
- themAre Trans People More Susceptible to Cardiovascular Disease? Researchers Still Have Questions
Researchers writing in the Journal of General Internal Medicine conclude that cardiovascular health risks for trans people, especially around hormone replacement therapy, are dangerously understudied. They note cardiovascular disease accounts for 26.4% of all U.S. deaths and that trans people, 1.1% of U.S. adults, appear to face disproportionate CVD rates regardless of whether they take hormones. The authors call for research beyond gender-affirming hormone therapy, including minority stress from stigma and discriminatory policies.
Heat over time
Not enough continuous observations yet to draw a trend.